- Open Access
Visualization of coronary venous anatomy by cardiovascular magnetic resonance
© Younger et al; licensee BioMed Central Ltd. 2009
- Received: 11 March 2009
- Accepted: 11 August 2009
- Published: 11 August 2009
Coronary venous imaging with whole-heart cardiovascular magnetic resonance (CMR) angiography has recently been described using developmental pulse sequences and intravascular contrast agents. However, the practical utility of coronary venous imaging will be for patients with heart failure in whom cardiac resynchronisation therapy (CRT) is being considered. As such complementary information on ventricular function and myocardial viability will be required. The aim of this study was to determine if the coronary venous anatomy could be depicted as part of a comprehensive CMR protocol and using a standard extracellular contrast agent.
Methods and Results
Thirty-one 3D whole heart CMR studies, performed after intravenous administration of 0.05 mmol/kg gadolinium DTPA, were reviewed. The cardiac venous system was visualized in all patients. The lateral vein of the left ventricle was present in 74%, the anterior interventricular vein in 65%, and the posterior interventricular vein in 74% of patients. The mean maximum distance of demonstrable cardiac vein on the 3D images was 81.5 mm and was dependent on the quality of the 3D data set. Five patients showed evidence of myocardial infarction on late gadolinium enhancement (LGE) images.
Coronary venous anatomy can be reliably demonstrated using a comprehensive CMR protocol and a standard extracellular contrast agent. The combination of coronary venous imaging, assessment of ventricular function and LGE may be useful in the management of patients with LV dysfunction being considered for CRT.
- Cardiovascular Magnetic Resonance
- Cardiac Resynchronization Therapy
- Late Gadolinium Enhancement
- Coronary Sinus
- Left Ventricular Lead
Cardiac resynchronization therapy (CRT) is now an established treatment for chronic heart failure with broad QRS duration . It requires the deployment of a left ventricular (LV) pacing lead to a branch of the cardiac venous system, usually via the coronary sinus. However this procedure is unsuccessful in 5–12% of patients for a variety of reasons including difficulty accessing the coronary sinus ostium, or lack of a suitable cardiac vein in which to position the LV lead . Prior knowledge of coronary venous anatomy may prove useful to cardiologists both in the selection of patients suitable for CRT and for the guidance of LV lead implantation.
Demonstration of cardiac venous anatomy is recognized as an appropriate indication for cardiac CT scanning . Coronary venous imaging with cardiovascular magnetic resonance (CMR) angiography has recently been described; however all previous studies have used either developmental pulse sequences or non-standard, intravascular contrast agents [4–6]. Late gadolinium enhancement (LGE) images, which can provide important complementary information for lead placement in CRT, were not acquired in these previous studies.
We sought to assess the feasibility and utility of using a three dimensional whole heart acquisition to visualize cardiac venous anatomy as part of a comprehensive CMR protocol that included myocardial function and viability scans and used a standard extracellular contrast agent.
The CMR angiograms of 31 patients (18 male; mean age 58 ± 11 yrs) were retrospectively evaluated for their ability to demonstrate coronary venous anatomy. The scans had been performed for coronary artery imaging as part of a comprehensive research protocol in patients with known or suspected ischemic heart disease. Each scan also included assessment of LV function, myocardial perfusion (not reported here) and scar (late gadolinium enhancement). The investigation conformed to the principles outlined in the Declaration of Helsinki, was approved by the local ethics committee, and written informed consent was obtained from all patients. Inclusion criteria were, suspected coronary artery disease, sinus rhythm, and weight <110 kg (to ensure that study participants would be likely to fit within the magnet bore). Exclusion criteria were any contraindication to CMR imaging or adenosine infusion, resting heart rate >100 bpm, renal failure, previous coronary artery bypass grafting or recent acute coronary syndrome.
All patients were examined supine in a 1.5 Tesla MRI scanner (Philips Medical Systems, Best, The Netherlands) equipped with master gradients (30 mT/m peak gradients and 150 mT/m/ms slew rate) and a 5 element dedicated cardiac phased array coil. Cardiac gating and triggering was performed via a vector ECG trace triggered on the R wave.
The position of the heart was determined by a rapid multislice, multistack survey scan in the transverse, coronal and sagittal planes. A low resolution coronary scout scan with a pencil beam respiratory navigator at the liver/lung border was performed to ensure adequate coverage of cardiac structures by the coronary imaging pulse sequence. High resolution coronary CMR angiography was then performed using a navigated 3D volume stack, with a steady state free precession sequence combined with fat suppression and T2 preparation prepulses (echo time 2.3 msec; repetition time 4.6 msec; flip angle 100°, SENSE factor of 1.7). The acquisition duration was individually adjusted to match the timing and length of the coronary rest period as determined from a horizontal long axis cine scan . Using sufficient slices to cover the entire cardiac volume (whole heart coronary angiography – WHCA), 110–130 axial slices were acquired with a typical field of view of 360 cm2 with an acquired spatial resolution of 1.18 × 1.18 × 1.80 mm3 which was reconstructed to a resolution of 0.7 × 0.7 × 0.9 mm3. All WHCA scans were commenced within 5 minutes of intravenous administration of 0.05 mmol/kg of a gadolinium based contrast agent (Gadolinium-DTPA – Magnevist, Schering AG, Germany) for perfusion assessment. A further 0.15 mmol/kg contrast was administered prior to LGE imaging.
A short axis cine stack with 10–12 slices was acquired with a steady state free precession pulse sequence for quantitative LV functional assessment. LGE imaging was commenced 10–15 minutes after administration of the final contrast bolus (10–12 slices, inversion recovery segmented k-space gradient echo pulse sequence inversion time set to null signal from normal myocardium, spatial resolution 1.2 × 1.2 × 10 mm3).
The images were transferred to a workstation (ViewForum – Philip's Medical Systems, Best, The Netherlands) equipped with commercially available advanced segmentation tools (Coro3D) and volume rendering software and hardware. The coronary sinus (CS) was identified on the axial scans and the image quality was visually assessed using a three point scale (1 = high; 2 = adequate; 3 = poor) similar to that used previously for grading CMR coronary artery scans [8, 9]. Subsequent results were grouped on the basis of the quality of the CS images; CS quality 1 where the axial images were of high quality, and CS quality 2/3 for sub optimal images. The data sets were then volume rendered and segmented to allow optimum visualization of the venous structures. The anatomy of the cardiac veins was studied on the 3-dimensional volume rendered image and in orthogonal planes using linked multi-planar reformatting and maximum intensity projections.
The dimensions of the CS and the presence of venous branches after volume rendering was recorded. The nomenclature used to describe the venous system is similar to that previously described , except that for simplification both posterior veins of the left ventricle and the left marginal vein were grouped together as left ventricular veins (LVV), as the area of venous drainage is similar. The diameter of the body of the CS on the axial and sagittal reformatted images, and the uninterrupted distance from the CS ostium to the most distal demonstrable end of a cardiac vein on the 3D image was measured. Presence of the anterior interventricular vein (AIV), posterior interventricular vein (PIV) and left ventricular branches were recorded, and the diameter of any left ventricular branches was assessed. The observer's confidence in the presence or absence of any LV branches was recorded on a 3 point scale (1 = reliable; 2 = probably reliable; 3 = not reliable).
Left ventricular mass and volumes were calculated by drawing the endocardial and epicardial contours on the end-diastolic and end-systolic images of the cine data sets and applying modified Simpson's rule. LGE images were analyzed visually for the presence of hyper-enhanced tissue in each of the LV short axis slices.
The software program SPSS 14.0 (SPSS Inc., Chicago, Illinois) was used for statistical analysis. Continuous data are presented as mean ± standard deviation. Dichotomous variables are presented as absolute number and percentage. Analysis of variance was used to study differences between groups. The independent t-test was used to study differences between mean values and Levene's test was used to assess equality of variances.
Characteristics of the study population
58 ± 11
56 ± 11
62 ± 11
82 ± 13
82 ± 15
83 ± 10
1.69 ± 0.09
1.69 ± 0.08
1.70 ± 0.10
28.7 ± 3.6
28.6 ± 3.7
28.9 ± 3.7
Resting Heart Rate (bpm)
64 ± 12
61 ± 13
68 ± 10
Late Gd Enhancement
MR quantitative data
Ejection Fraction (%)
53.1 ± 7.3
54.6 ± 3.5
51.5 ± 10.5
Cardiac Output (l/min)
5.2 ± 1.0
5.2 ± 1.3
5.2 ± 0.9
157.9 ± 39.1
158.1 ± 35.5
157.7 ± 45.0
LV Mass (g)
92.6 ± 21.9
86.7 ± 24.5
100.8 ± 15.2
Coronary venous anatomy
2.6 ± 0.8
2.6 ± 1.0
2.5 ± 0.4
Max distance (mm)
81.5 ± 43.6
96.5 ± 41.8
60.9 ± 38.7*
CS Diameters (mm)
9.9 ± 2.9
10.7 ± 3.1
8.8 ± 2.4
11.5 ± 2.9
12.7 ± 2.9
9.8 ± 1.8*
The confidence in assessing venous tributaries was significantly lower for the presence of LLV branches on the lower quality vs. the higher quality scans (mean score 2.2 vs. 1.1), although the diameter of any measured branches was similar in both groups (Table 2). In 2 patients no venous branches other than the CS and great cardiac vein could be seen (one of these was CS quality 1, the other was CS quality 3).
The diameter of the coronary sinus was larger in the supero-inferior direction, than in the antero-posterior direction, in all groups as detailed in Table 2. Although there was no significant difference in the antero-posterior dimensions between the two groups, those in CS quality 1 had a significantly larger supero-inferior dimension than those in CS quality 2/3.
We have shown that CMR imaging of the coronary venous system can be performed as part of a comprehensive CMR protocol which includes myocardial perfusion, LV function and viability assessment and using a standard extravascular contrast agent. The techniques described in this study may be applicable to patients with heart failure undergoing CMR that are being considered for CRT.
CMR is already recognized as an important imaging modality for patients with heart failure, both in defining the aetiology and assessing the degree of LV dysfunction. In particular, patterns of scar tissue demonstrated by LGE imaging can be used to differentiate ischemic and non-ischemic origins, potentially avoiding invasive X-ray coronary angiography . However CMR could also potentially provide information directly relevant to patients being considered for CRT. Firstly, a large scar burden, as detected by LGE imaging, is an important factor in predicting a lack of response to CRT, and has been proposed for inclusion in the selection process of CRT candidates . Secondly, a recent study has indicated that CRT is less effective if the LV lead is placed in a vein overlying transmural scar in the postero-lateral LV wall . Scar assessment with LGE is therefore an essential component of a CMR protocol in heart failure. Relating scar distribution to venous anatomy, as shown in Figure 3, potentially allows guidance of LV lead placement to areas of viable myocardium. The third application by which CMR could guide CRT is by providing prior knowledge of coronary venous anatomy. Location of the LV lead in a lateral vein, compared with lead placement in other locations, results in greater reverse LV remodelling and reduced diastolic dyssynchrony . Hence patients with absence of lateral veins may not be ideal candidates for CRT.
The main appeal of using CMR imaging in patients considered for CRT is that in a single examination CMR could accurately assess left ventricular function, define venous anatomy, and assess both the aetiology of the heart failure and likelihood of response to CRT using total scar burden and location of scar tissue. Until recently, non invasive venous imaging was only possible using multi-detector CT (MDCT). However widespread use of MDCT is restricted by the necessity for large doses of both ionising radiation and iodinated contrast media. Furthermore, MDCT is generally restricted to assessment of the coronary vessels. The limited temporal resolution reduces the accuracy of MDCT for assessment of LV function when compared to modalities such as CMR or echocardiography , and, while MDCT has been proposed for viability assessment, this is not yet an established technique and leads to additional radiation exposure [16, 17].
Several recent publications have demonstrated the ability of WHCA to delineate the course of the coronary veins in a three dimensional volume that can be reconstructed and volume rendered in a manner similar to MDCT [4–6]. The slow blood flow velocity and anatomic variability of coronary veins make them a challenging target for CMR imaging, so that intravascular contrast agents were used to enhance the coronary venous system in two of these three studies. However, intravascular contrast agents are not currently licensed for cardiac use and do not allow an assessment of LGE, which relies on contrast leakage into the extravascular space. Our data therefore complement the existing evidence for coronary venous CMR by showing that the coronary veins can also be imaged using a standard gadolinium-based contrast agent and in combination with myocardial function and LGE imaging. We expect that such combined assessment will be the most powerful clinical application for CMR in heart failure assessment and will distinguish it from MDCT. Importantly, measurements of the coronary venous system depicted in our study were similar to the results of previous studies using MDCT .
Our data also show that the delineation of the coronary venous system is dependent on the quality of the acquired data. For high resolution CMR whole heart imaging, data are acquired over many RR intervals (mean nominal scan time in our study was 5.32 minutes), so that the method is sensitive to changes in respiratory patterns and patient movement, as well as heart rate variation. The respiratory navigator can correct partially for bulk cardiac motion and arrhythmia rejection algorithms are available to limit the effects of heart rate changes, but in clinical practice around one third of WHCA studies are of impaired quality. These general limitations of CMR WHCA were also reflected in our study.
The CMR WHCA pulse sequence used in this study was designed to provide optimal visualization of the epicardial coronary arteries, and may therefore be suboptimal for demonstration of the coronary venous system. Further studies will be required to define the best methodology to reliably demonstrate cardiac venous anatomy by CMR. To our knowledge invasive venography, using retrograde contrast injection via the CS, has not yet been used to evaluate any non-invasive method of venous visualization. Without performing retrograde venography on all patients the true value of either CMR or MDCT to predict the anatomy of cardiac veins cannot be known. Hence the frequency with which CMR demonstrated venous branches in this study may be related both to the patient group or to the imaging modality and the relative contribution of each of these factors cannot be assessed. Finally the efficacy of CMR for coronary venous assessment specifically in patients with severe heart failure and broad QRS duration has not yet been assessed and may prove more challenging.
Coronary venous anatomy can be demonstrated as part of a comprehensive CMR protocol that also includes late gadolinium enhanced imaging with a standard extracellular contrast agent. This may prove a useful addition to standard CMR in the assessment of patients with LV dysfunction who are being considered for CRT.
This work was undertaken on the British Heart Foundation research CMR imaging system. Data from this study were presented at the Society of Cardiovascular Magnetic Resonance Scientific Sessions, Rome, Feb 2007 (Younger et al. Visualisation of the coronary venous system with a three dimensional single volume cardiac magnetic resonance protocol. JCMR 2007;9(2):358-259).
- Bleasdale RA, Frenneaux MP: Cardiac resynchronisation therapy: when the drugs don't work. Heart. 2004, 90 (Suppl 6): vi2-vi4. 10.1136/hrt.2004.048546.PubMed CentralPubMedGoogle Scholar
- Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al: Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002, 346: 1845-53. 10.1056/NEJMoa013168.View ArticlePubMedGoogle Scholar
- Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC, et al: ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006, 48: 1475-97. 10.1016/j.jacc.2006.07.003.View ArticlePubMedGoogle Scholar
- Nezafat R, Han Y, Yeon S, Peters DC, Wylie J, Zimetbaum J, et al: MR Coronary Vein Imaging in Cardiac Resynchronization Therapy: Initial Experience. J Cardiovasc Magn Reson. 2007, 9: 139-40.Google Scholar
- Rasche V, Binner L, Cavagna F, Hombach V, Kunze M, Spiess J, et al: Whole-heart coronary vein imaging: a comparison between non-contrast-agent- and contrast-agent-enhanced visualization of the coronary venous system. Magn Reson Med. 2007, 57: 1019-26. 10.1002/mrm.21228.View ArticlePubMedGoogle Scholar
- Chiribiri A, Kelle S, Götze S, et al: Visualization of the Cardiac Venous System Using Cardiac Magnetic Resonance. The American Journal of Cardiology. 2008, 101: 407-412. 10.1016/j.amjcard.2007.08.049.View ArticlePubMedGoogle Scholar
- Plein S, Jones TR, Ridgway JP, Sivananthan MU: Three-dimensional coronary MR angiography performed with subject-specific cardiac acquisition windows and motion-adapted respiratory gating. AJR Am J Roentgenol. 2003, 180: 505-12.View ArticlePubMedGoogle Scholar
- Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, et al: Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001, 345: 1863-9. 10.1056/NEJMoa010866.View ArticlePubMedGoogle Scholar
- Jahnke C, Paetsch I, Nehrke K, Schnackenburg B, Gebker R, Fleck E, et al: Rapid and complete coronary arterial tree visualization with magnetic resonance imaging: feasibility and diagnostic performance. European Heart Journal. 2005, 26: 2313-9. 10.1093/eurheartj/ehi391.View ArticlePubMedGoogle Scholar
- Jongbloed MR, Lamb HJ, Bax JJ, Schuijf JD, de Roos A, van der Wall EE, et al: Noninvasive visualization of the cardiac venous system using multislice computed tomography. J Am Coll Cardiol. 2005, 45: 749-53. 10.1016/j.jacc.2004.11.035.View ArticlePubMedGoogle Scholar
- McCrohon JA, Moon JCC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS, et al: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003, 108: 54-9. 10.1161/01.CIR.0000078641.19365.4C.View ArticlePubMedGoogle Scholar
- Ypenburg C, Roes SD, Bleeker GB, Kaandorp TA, de Roos A, Schalij MJ, et al: Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol. 2007, 99: 657-60. 10.1016/j.amjcard.2006.09.115.View ArticlePubMedGoogle Scholar
- Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, et al: Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006, 113: 969-76. 10.1161/CIRCULATIONAHA.105.543678.View ArticlePubMedGoogle Scholar
- Rovner A, de Las FL, Faddis MN, Gleva MJ, Davila-Roman VG, Waggoner AD: Relation of left ventricular lead placement in cardiac resynchronization therapy to left ventricular reverse remodeling and to diastolic dyssynchrony. Am J Cardiol. 2007, 99: 239-41. 10.1016/j.amjcard.2006.07.086.View ArticlePubMedGoogle Scholar
- Chan J, Jenkins C, Khafagi F, Du L, Marwick TH: What is the optimal clinical technique for measurement of left ventricular volume after myocardial infarction? A comparative study of 3-dimensional echocardiography, single photon emission computed tomography, and cardiac magnetic resonance imaging. J Am Soc Echocardiogr. 2006, 19: 192-201. 10.1016/j.echo.2005.08.020.View ArticlePubMedGoogle Scholar
- Mahnken AH, Koos R, Katoh M, Wildberger JE, Spuentrup E, Buecker A, et al: Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol. 2005, 45: 2042-7. 10.1016/j.jacc.2005.03.035.View ArticlePubMedGoogle Scholar
- Lardo AC, Cordeiro MA, Silva C, Amado LC, George RT, Saliaris AP, et al: Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation. 2006, 113: 394-404. 10.1161/CIRCULATIONAHA.105.521450.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.